Replies to post #4464 on Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

I'm still around. My attention is on other companies right now that I believe have a greater likelihood of making a big move in the next year. I still love the idea of PEGPH20 and the ph2 results this fall might take it back into the 20s. There is some risk though as, IMO, the follow-thru on the stage 1 data fell flat. Also, not a fan of pursuing non-HA based drugs at this point in company development.

I hope to become fully invested again in the future. Maybe after I see how ph2 results look - and how frankly HALO discusses those results - I could be back in a big way.